Elevance Health, Inc. Common Stock (ELV)
277.09
-25.36 (-8.38%)
NYSE · Last Trade: Jul 19th, 1:42 PM EDT
Detailed Quote
Previous Close | 302.45 |
---|---|
Open | 290.31 |
Bid | 276.57 |
Ask | 277.25 |
Day's Range | 276.41 - 293.31 |
52 Week Range | 276.41 - 567.26 |
Volume | 8,394,478 |
Market Cap | 64.47B |
PE Ratio (TTM) | 11.76 |
EPS (TTM) | 23.6 |
Dividend & Yield | 6.840 (2.47%) |
1 Month Average Volume | 2,499,863 |
Chart
News & Press Releases
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Via StockStory · July 18, 2025
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · July 18, 2025
Invesco, Vistra, Dell, Coinbase Trend In Midday Trade: S&P 500 Hits Record Highstocktwits.com
Via Stocktwits · July 18, 2025
States Sue to Block HHS Rule Cutting Health Coverage; ICE Use of Medicaid Data Sparks Outcrystocktwits.com
Via Stocktwits · July 17, 2025
Elevance Stock Slips After Wells Fargo Cuts Price Target Ahead Of Q2 Earnings: Retail’s Not Pessimistic Yetstocktwits.com
Via Stocktwits · July 15, 2025
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below.
Via Chartmill · July 18, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · July 18, 2025
Stay updated with the S&P500 gap up and gap down stocks on Friday. Get a glimpse of the market's movement during today's session.
Via Chartmill · July 18, 2025
Via Benzinga · July 18, 2025
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · July 17, 2025
Let's have a look at the S&P500 stocks with an unusual volume in today's session.
Via Chartmill · July 17, 2025
U.S. equities climbed on Thursday, with the S&P 500 briefly testing a record high 6,300 level at midday in New York, bolstered by strong earnings and upbeat retail sales data that reinforced investor risk appetite.
Via Benzinga · July 17, 2025
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Via Chartmill · July 17, 2025
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Via Chartmill · July 17, 2025
Elevance Health topped Q2 revenue estimates but missed on EPS and cut its 2025 guidance due to rising medical cost trends in Medicaid and ACA.
Via Benzinga · July 17, 2025
The health insurer now expects its adjusted net income per diluted share to be approximately $30.00, down from its previous guidance of $34.15 to $34.85.
Via Stocktwits · July 17, 2025
Health insurance provider Elevance Health (NYSE:EVH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 13.4% year on year to $49.78 billion. Its non-GAAP profit of $8.84 per share was 1.4% below analysts’ consensus estimates.
Via StockStory · July 17, 2025
Elevance Health, Inc. (NYSE: ELV) reported second quarter 2025 results.
By Elevance Health, Inc. · Via Business Wire · July 17, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 15, 2025
Via Benzinga · July 14, 2025
UnitedHealth delays Q2 report to July 29 as insurer earnings season begins with cost pressures clouding 2025 outlooks across the sector.
Via Benzinga · July 14, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance Health (ELV) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 11, 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · July 11, 2025